Literature DB >> 33298211

Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019.

Jacqueline T Bork1, Surbhi Leekha1,2, Kimberly Claeys3, Hyunuk Seung3, Megan Tripoli2, Anthony Amoroso1, Emily L Heil3.   

Abstract

Interrupted time series segmented regression was conducted to trend antibiotic use and multidrug-resistant gram-negative (MDRGN) acquisition relative to COVID-19 in an academic hospital. Total antibiotic use and antibiotic use related to pneumonia was higher in the period after the onset of COVID-19 compared to the similar calendar period in 2019. Furthermore, MDRGN acquisition increased 3% for every increase in positive COVID-19 tests per week.

Entities:  

Year:  2020        PMID： 33298211      PMCID： PMC7783138          DOI： 10.1017/ice.2020.1360

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

Review 1.  Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.

Authors:  Timothy M Rawson; Luke S P Moore; Nina Zhu; Nishanthy Ranganathan; Keira Skolimowska; Mark Gilchrist; Giovanni Satta; Graham Cooke; Alison Holmes
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

Review 2.  Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli.

Authors:  Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2006-09-01       Impact factor: 9.079

3.  Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia.

Authors:  Spinello Antinori; Laura Galimberti; Laura Milazzo; Anna Lisa Ridolfo
Journal:  Infez Med       Date:  2020-06-01

4.  Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.

Authors:  Daniel B Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-02-28       Impact factor: 17.586

5.  Improving antibiotic stewardship in COVID-19: Bacterial co-infection is less common than with influenza.

Authors:  Jonathan Youngs; Duncan Wyncoll; Philip Hopkins; Amber Arnold; Jonathan Ball; Tihana Bicanic
Journal:  J Infect       Date:  2020-06-25       Impact factor: 6.072

6.  Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.

Authors:  Valerie M Vaughn; Tejal N Gandhi; Lindsay A Petty; Payal K Patel; Hallie C Prescott; Anurag N Malani; David Ratz; Elizabeth McLaughlin; Vineet Chopra; Scott A Flanders
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

7.  COVID-19: don't neglect antimicrobial stewardship principles!

Authors:  B D Huttner; G Catho; J R Pano-Pardo; C Pulcini; J Schouten
Journal:  Clin Microbiol Infect       Date:  2020-04-30       Impact factor: 8.067

8.  Inpatient antibiotic utilization in the Veterans' Health Administration during the coronavirus disease 2019 (COVID-19) pandemic.

Authors:  Thomas D Dieringer; Daisuke Furukawa; Christopher J Graber; Vanessa W Stevens; Makoto M Jones; Michael A Rubin; Matthew Bidwell Goetz
Journal:  Infect Control Hosp Epidemiol       Date:  2020-10-20       Impact factor: 3.254

9.  COVID-19 and the potential long-term impact on antimicrobial resistance.

Authors:  Timothy M Rawson; Luke S P Moore; Enrique Castro-Sanchez; Esmita Charani; Frances Davies; Giovanni Satta; Matthew J Ellington; Alison H Holmes
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

10.  Impact of COVID-19 on pneumonia-focused antibiotic use at an academic medical center.

Authors:  Matthew J Nestler; Emily Godbout; Kimberly Lee; Jihye Kim; Andrew J Noda; Perry Taylor; Rachel Pryor; J Daniel Markley; Michelle Doll; Gonzalo Bearman; Michael P Stevens
Journal:  Infect Control Hosp Epidemiol       Date:  2020-07-23       Impact factor: 3.254
  10 in total
  10 in total

Review 1.  The Complexity of Co-Infections in the Era of COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-04-23

Review 2.  Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review.

Authors:  Francesco Vladimiro Segala; Davide Fiore Bavaro; Francesco Di Gennaro; Federica Salvati; Claudia Marotta; Annalisa Saracino; Rita Murri; Massimo Fantoni
Journal:  Viruses       Date:  2021-10-20       Impact factor: 5.048

Review 3.  Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies.

Authors:  Alessia Catalano; Domenico Iacopetta; Jessica Ceramella; Domenica Scumaci; Federica Giuzio; Carmela Saturnino; Stefano Aquaro; Camillo Rosano; Maria Stefania Sinicropi
Journal:  Molecules       Date:  2022-01-18       Impact factor: 4.411

4.  Bacterial infections and antibiotic utilization varies by coronavirus disease 19 (COVID-19) severity in hospitalized cancer patients: Analysis from the first phase of the pandemic.

Authors:  Susan K Seo; Nina Cohen; Kayla R Maki; Samantha N Steiger; Yiqi Su; Aida Boumiza; Carrie A Tan; Marina Kerpelev
Journal:  Infect Control Hosp Epidemiol       Date:  2022-05-26       Impact factor: 6.520

5.  A cross-sectional study of antimicrobial use among self-medicating COVID-19 cases in Nyeri County, Kenya.

Authors:  George Kimathi; Jackline Kiarie; Lydiah Njarambah; Jorum Onditi; David Ojakaa
Journal:  Antimicrob Resist Infect Control       Date:  2022-08-30       Impact factor: 6.454

6.  Diminishing returns, increasing risks: Impact of antibiotic duration of therapy on respiratory bacterial isolates in hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemic.

Authors:  Catherine Li; Ryan W Chapin; Nicholas J Mercuro; Christina F Yen; Howard S Gold; Matthew S L Lee; Christopher McCoy
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-07-23

Review 7.  Antibiotic Resistance during COVID-19: A Systematic Review.

Authors:  Hadi Jaber Al Sulayyim; Rohani Ismail; Abdullah Al Hamid; Noraini Abdul Ghafar
Journal:  Int J Environ Res Public Health       Date:  2022-09-21       Impact factor: 4.614

8.  Multidrug Resistence Prevalence in COVID Area.

Authors:  Caterina Aurilio; Pasquale Sansone; Antonella Paladini; Manlio Barbarisi; Francesco Coppolino; Vincenzo Pota; Maria Caterina Pace
Journal:  Life (Basel)       Date:  2021-06-23

Review 9.  Review on Multiple Facets of Drug Resistance: A Rising Challenge in the 21st Century.

Authors:  Mousumi Saha; Agniswar Sarkar
Journal:  J Xenobiot       Date:  2021-12-13

Review 10.  Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic.

Authors:  Hung-Jen Tang; Chih-Cheng Lai; Chien-Ming Chao
Journal:  Antibiotics (Basel)       Date:  2022-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.